Practice diversity among US stroke physicians with respect to the 3- to 4·5-h window

International Journal of Stroke

Volumn 10, Issue 3, 2015, Pages E24-E25

  Mutgi, Sunil A ^a   Behrouz, Réza ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

BRAIN ISCHEMIA; HEALTH SURVEY; HUMAN; INFORMED CONSENT; LETTER; NEUROLOGIST; OFF LABEL DRUG USE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTER; TREATMENT INDICATION; UNITED STATES; CLINICAL PRACTICE; PHYSICIAN; STROKE; TIME FACTOR;

HEALTH SURVEYS; HUMANS; PHYSICIANS; PRACTICE PATTERNS, PHYSICIANS'; STROKE; TIME FACTORS; UNITED STATES;

EID: 84924807350     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12443     Document Type: Letter

References (5)

1. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009; 40:2945-2948.
2. Jauch EC, Saver JL, Adams HP Jr. etal. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44:870-947.
3. Hacke W, Kaste M, Bluhmki E etal. Thrombolysis with alteplase 3 to 4·5 hours after acute ischemic stroke. N Engl J Med 2008; 359:1317-1329.
4. Messé SR, Fonarow GC, Smith EE etal. Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With the Guidelines-Stroke. Circ Cardiovasc Qual Outcomes 2012; 5:321-326.
5. Tekle WG, Chaudhry SA, Hassan AE etal. Utilization of intravenous thrombolysis in 3-4·5 hours: analysis of the Minnesota Stroke Registry. Cerebrovasc Dis 2012; 34:400-405.